EUVIMEDEUVIMED entdecken
Crossref

Synthetic somatostatin analogs ameliorate endothelial injury due to hydrochloric acid treatment

Saikat Fakir, Khadeja-Tul Kubra, Madan Sigdel, Md Matiur Rahman Sarker, Nektarios Barabutis

Environmental Toxicology and Pharmacology · 2026-06 · 124 · 104999

DOI: 10.1016/j.etap.2026.104999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology and Pharmacology, 2026-06. Verfasst von Saikat Fakir und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, United States. Hauptthemen laut MEDLINE: Somatostatin, Hydrochloric Acid, Endothelial Cells, Octreotide. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial barrier dysfunction is a key feature of lung injury induced by hydrogen chloride gas, which is converted to HCl in tissues. Synthetic somatostatin analogs (SSA), such as Lanreotide and Octreotide, are prescribed in clinics for acromegaly and neuroendocrine tumor treatment. Recent findings suggest that those FDA-approved drugs can ameliorate inflammatory lung disease. This study aims to assess the potential protective effects of SSA against HCL-induced endothelial injury in vitro, utilizing bovine pulmonary artery endothelial cells. Our observations suggest that HCL exposure impairs endothelial cell viability and proliferation, increases paracellular and transendothelial permeability, and induces reactive oxygen species generation, as expected. Octreotide and Lanreotide treatment alleviate the aforementioned toxic effects and exert anti-inflammatory effects in the impaired endothelial cells. Those data inform us on the potential protective effects of SSA in HCL-induced endothelial injury and inflammation, suggesting that they could be repurposed to ameliorate respiratory complications due to toxicant exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SomatostatinHydrochloric AcidEndothelial CellsOctreotidePeptides, CyclicAnti-Inflammatory AgentsAnimalsCattleCell SurvivalReactive Oxygen SpeciesCell ProliferationPulmonary ArteryCells, Cultured

Stichwörter der Autor:innen

DysfunctionEndotheliumInflammationPermeability

Substanzen

SomatostatinHydrochloric AcidOctreotideReactive Oxygen SpecieslanreotidePeptides, CyclicAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, United States.
  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, United States. Electronic address: barabutis@ulm.edu.

Zitieren

APA

Fakir, S., Kubra, K. T., Sigdel, M., Sarker, M. M. R., & Barabutis, N. (2026). Synthetic somatostatin analogs ameliorate endothelial injury due to hydrochloric acid treatment. Environmental Toxicology and Pharmacology, 124, 104999. https://doi.org/10.1016/j.etap.2026.104999

Vancouver

Fakir S, Kubra KT, Sigdel M, Sarker MMR, Barabutis N. Synthetic somatostatin analogs ameliorate endothelial injury due to hydrochloric acid treatment. Environmental Toxicology and Pharmacology. 2026;124:104999. doi:10.1016/j.etap.2026.104999

BibTeX
@article{Fakir2026,
  author = {Fakir, Saikat and Kubra, Khadeja-Tul and Sigdel, Madan and Sarker, Md Matiur Rahman and Barabutis, Nektarios},
  title = {Synthetic somatostatin analogs ameliorate endothelial injury due to hydrochloric acid treatment},
  journal = {Environmental Toxicology and Pharmacology},
  year = {2026},
  volume = {124},
  pages = {104999},
  doi = {10.1016/j.etap.2026.104999}
}
Kostenlos starten →